Prism Medico And Pharmacy Share Price
Sector: Personal & Household Prods.
16.46 -0.04 (-0.24%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
15.70
Today’s High
17.28
52 Week Low
11.62
52 Week High
37.20
Key Metrics
- Market Cap (In Cr) 9.98
- Beta -0.1
- Div. Yield (%) 0
- P/B 0.66
- TTM P/E -
- Peg Ratio -
- Sector P/E 17.7
- Open Price 17.28
- Prev Close 16.5
Prism Medico And Pharmacy Analysis
Price Analysis
-
1 Week20.26%
-
3 Months7.77%
-
6 Month-34.47%
-
YTD-32.04%
-
1 Year-28.14%
Risk Meter
- 50% Low risk
- 50% Moderate risk
- 50% Balanced Risk
- 50% High risk
- 50% Extreme risk
Prism Medico And Pharmacy Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2.93
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.47
- Total Operating Expense
- 3.07
- Operating Income
- -0.14
- Net Income Before Taxes
- -0.03
- Net Income
- -0.03
- Diluted Normalized EPS
- -0.04
- Period
- 2024
- Total Assets
- 15.24
- Total Liabilities
- 0.1
- Total Equity
- 15.14
- Tangible Book Valueper Share Common Eq
- 24.97
- Period
- 2024
- Cashfrom Operating Activities
- -0.01
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.01
- Net Changein Cash
- -0.01
- Period
- 2023
- Total Revenue
- 1.27
- Selling/ General/ Admin Expenses Total
- 0.05
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.18
- Total Operating Expense
- 1.37
- Operating Income
- -0.1
- Net Income Before Taxes
- -0.1
- Net Income
- -0.08
- Diluted Normalized EPS
- -0.13
- Period
- 2023
- Total Assets
- 15.39
- Total Liabilities
- 0.23
- Total Equity
- 15.16
- Tangible Book Valueper Share Common Eq
- 25
- Period
- 2023
- Cashfrom Operating Activities
- 2.95
- Cashfrom Investing Activities
- -2.91
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.04
- Period
- 2022
- Total Revenue
- 8.44
- Selling/ General/ Admin Expenses Total
- 0.19
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.12
- Total Operating Expense
- 8.94
- Operating Income
- -0.5
- Net Income Before Taxes
- -0.5
- Net Income
- -0.37
- Diluted Normalized EPS
- -0.61
- Period
- 2022
- Total Assets
- 12.57
- Total Liabilities
- 0.02
- Total Equity
- 12.55
- Tangible Book Valueper Share Common Eq
- 20.71
- Period
- 2022
- Cashfrom Operating Activities
- -2.38
- Cashfrom Investing Activities
- 2.35
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.03
- Period
- 2021
- Total Revenue
- 16.76
- Selling/ General/ Admin Expenses Total
- 0.17
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 16.94
- Operating Income
- -0.17
- Net Income Before Taxes
- -0.18
- Net Income
- -0.13
- Diluted Normalized EPS
- -0.21
- Period
- 2021
- Total Assets
- 21.54
- Total Liabilities
- 8.62
- Total Equity
- 12.93
- Tangible Book Valueper Share Common Eq
- 21.32
- Period
- 2021
- Cashfrom Operating Activities
- -0.04
- Cashfrom Investing Activities
- 0.02
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.03
- Period
- 2020
- Total Revenue
- 26.89
- Selling/ General/ Admin Expenses Total
- 0.22
- Depreciation/ Amortization
- 0.02
- Other Operating Expenses Total
- 0.11
- Total Operating Expense
- 26.96
- Operating Income
- -0.07
- Net Income Before Taxes
- -0.07
- Net Income
- -0.05
- Diluted Normalized EPS
- -0.08
- Period
- 2020
- Total Assets
- 21.58
- Total Liabilities
- 8.53
- Total Equity
- 13.06
- Tangible Book Valueper Share Common Eq
- 21.53
- Period
- 2020
- Cashfrom Operating Activities
- -4.3
- Cashfrom Investing Activities
- 4.36
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.01
- Period
- 2019
- Total Revenue
- 54.43
- Selling/ General/ Admin Expenses Total
- 0.27
- Depreciation/ Amortization
- 0.38
- Other Operating Expenses Total
- 0.83
- Total Operating Expense
- 54.71
- Operating Income
- -0.29
- Net Income Before Taxes
- -0.1
- Net Income
- 0.04
- Diluted Normalized EPS
- 0.07
- Period
- 2019
- Total Assets
- 21.2
- Total Liabilities
- 8.29
- Total Equity
- 12.91
- Tangible Book Valueper Share Common Eq
- 21.3
- Period
- 2019
- Cashfrom Operating Activities
- -18.1
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.5
- Net Changein Cash
- -0.94
- Period
- 2024-12-31
- Total Revenue
- 0.21
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 0.22
- Operating Income
- -0.01
- Net Income Before Taxes
- -0.01
- Net Income
- -0.01
- Diluted Normalized EPS
- -0.02
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 0.29
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 0.28
- Operating Income
- 0.01
- Net Income Before Taxes
- 0.01
- Net Income
- 0.01
- Diluted Normalized EPS
- 0.02
- Period
- 2024-09-30
- Total Assets
- 15.16
- Total Liabilities
- 0.1
- Total Equity
- 15.06
- Tangible Book Valueper Share Common Eq
- 24.84
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0
- Period
- 2024-06-30
- Total Revenue
- 0.06
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 0.15
- Operating Income
- -0.09
- Net Income Before Taxes
- -0.09
- Net Income
- -0.09
- Diluted Normalized EPS
- -0.15
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 0.15
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.19
- Total Operating Expense
- 0.31
- Operating Income
- -0.17
- Net Income Before Taxes
- -0.07
- Net Income
- -0.08
- Diluted Normalized EPS
- -0.11
- Period
- 2024-03-31
- Total Assets
- 15.24
- Total Liabilities
- 0.1
- Total Equity
- 15.14
- Tangible Book Valueper Share Common Eq
- 24.97
- Period
- 2024-03-31
- Period
- 2023-12-31
- Total Revenue
- 2.75
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.15
- Total Operating Expense
- 2.55
- Operating Income
- 0.19
- Net Income Before Taxes
- 0.19
- Net Income
- 0.19
- Diluted Normalized EPS
- 0.31
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Prism Medico And Pharmacy Technical
Moving Average
SMA
- 5 Day14.8
- 10 Day14.23
- 20 Day14.29
- 50 Day14.48
- 100 Day17.1
- 300 Day22.03
Prism Medico And Pharmacy Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Yarn Syndicate
- 17.82
- 0.28
- 1.6
- 61
- 15.91
- 38.76
- Sirohia And Sons
- 11.19
- 0
- 0
- 16.43
- 6.94
- 11.48
- Prism Medico And Pharmacy
- 16.46
- -0.04
- -0.24
- 37.2
- 11.62
- 9.98
- Prashant India
- 13.61
- 0.26
- 1.95
- 16.67
- 7.77
- 5.76
- Aviva Industries
- 37.31
- 0
- 0
- 37.31
- 23.5
- 5.59
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Yarn Syndicate
- 10.52
- 1.59
- -0.42
- -1.18
- Sirohia And Sons
- 161.4
- 0.41
- -
- -
- Prism Medico And Pharmacy
- -
- 0.65
- -0.96
- -1.17
- Prashant India
- -
- -
- -
- -13.6
- Aviva Industries
- -
- 1.8
- -0.11
- -1.13
Prism Medico And Pharmacy Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results
- 14-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 16-Sept-24
- AGM
- 30-Sept-23
- 14-Sept-23
- AGM
- 14-Aug-23
- 20-Jul-23
- EGM
- 30-Sept-22
- 05-Sept-22
- AGM



